Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
56.48 USD | -0.61% | +7.16% | +118.68% |
05-08 | Transcript : Establishment Labs Holdings Inc., Q1 2024 Earnings Call, May 08, 2024 | |
05-08 | Establishment Labs Holdings Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Strengths
- According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
- Sales forecast by analysts have been recently revised upwards.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Over the past four months, analysts' average price target has been revised upwards significantly.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company has insufficient levels of profitability.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- Based on current prices, the company has particularly high valuation levels.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+118.68% | 1.56B | B- | ||
-4.87% | 182B | C+ | ||
+0.47% | 110B | C | ||
-3.49% | 67.92B | A | ||
+2.24% | 50.96B | B- | ||
+9.28% | 44.7B | B- | ||
+2.70% | 40.66B | B+ | ||
+24.21% | 27.6B | B | ||
+3.72% | 26.63B | A- | ||
-0.49% | 24.98B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- ESTA Stock
- Ratings Establishment Labs Holdings Inc.